Nutrigenomics is the science domain that helps in determining the association between nutritional diet, healthcare, and the human genome. It further aids in understanding an individual’s food intakes and how the entire human system reacts to various foods. Nutrigenomics also involves studying biomarkers and single gene expression.
Growing occurrences of metabolic ailments, increasing overweight population globally, and rising utilization of nutrigenomics in the dermatology field are the major growth drivers of the global nutrigenomics market. Furthermore, cumulative healthcare spending and government support for various research & development activities and ongoing advancements in technology along with the escalating demand for advanced diagnostic methods are fuelling the global nutrigenomics market growth. However, the shortage of qualified healthcare service providers and professionals and high treatment cost may limit the global nutrigenomics market. Nevertheless, the growing popularity of food that is rich in nutrients will create new growth opportunities, thereby nullifying the negative effects of various market obstructions. Additionally, the increasing competition among major players operating in the global nutrigenomics market for developing innovative test kits or solutions is expected to further propel this market in the future.
The global nutrigenomics market is fragmented on the basis of product type and application. On the basis of product type, the global nutrigenomics market includes reagents and kits and services. Based on application, the market includes cardiovascular diseases, obesity, cancer, and other chronic diseases.
North America is likely to contribute substantially to the global nutrigenomics market in the years ahead. This can be attributed to the launch of direct consumer nutrigenomics supply channels, and escalating ingestion of specialized diet, and the introduction of the latest technologies and biotechnologies in the food sector. In addition, the U.S. and Canada have huge numbers of obese patients and patients suffering from lifestyle-related disorders, such as diabetes. This, in turn, will further fuel this regional market’s growth in the future. The Asia Pacific nutrigenomics market is likely to witness considerable growth in the years ahead, owing to the rising demand for functional foods and beverages that has boosted the adoption of nutrigenomics techniques. Growing spending on healthcare and increasing demand for holistic treatment along with rising health-consciousness of the regional population will also contribute majorly to the Asia Pacific nutrigenomics market. Additionally, Japan is projected to be the major regional consumer of functional foods over the forecast time period.
Some major companies operating in the global nutrigenomics market are DSM N.V., Koninklijke, BASF, GeneSmart, Unilever, Danone, Genova Diagnostics, Metagenics, Nutrigenomix, WellGen, and Cell Logic.